- Home
- JAKK vs FENC Comparison
JAKK vs FENC Comparison
Compare JAKK & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JAKK | FENC |
|---|---|---|
| Founded | 1995 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.2M | 266.4M |
| IPO Year | 1996 | 2010 |
Fundamental Metrics
Financial Performance| Metric | JAKK | FENC |
|---|---|---|
| Price | $20.09 | $6.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $35.00 | $15.00 |
| AVG Volume (30 Days) | 70.0K | ★ 191.9K |
| Earning Date | 04-28-2026 | 03-24-2026 |
| Dividend Yield | ★ 5.02% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $331,249,000.00 | $44,642,000.00 |
| Revenue This Year | $9.46 | $75.81 |
| Revenue Next Year | $4.36 | $25.06 |
| P/E Ratio | $23.16 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.87 | $4.68 |
| 52 Week High | $23.25 | $9.92 |
Technical Indicators
Market Signals| Indicator | JAKK | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 40.40 |
| Support Level | $20.21 | N/A |
| Resistance Level | $21.06 | $9.09 |
| Average True Range (ATR) | 0.67 | 0.47 |
| MACD | -0.06 | -0.12 |
| Stochastic Oscillator | 63.64 | 31.71 |
Price Performance
Historical ComparisonAbout JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells, and distributes toys and related kid-targeted consumer products, including kids' indoor and outdoor furniture, costumes, and various product lines in the sporting goods and home furnishings space. Its product offerings include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: Toys/Consumer Products and Costumes. It generates the majority of its revenue from the Toys/Consumer Products segment.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.